Hypnotherapy for adolescents and adults with inflammatory bowel disease and symptoms compatible with irritable bowel syndrome

Phase 3

Conditions: Crohns disease
inflammatory bowel disease
Ulcerative Colitis
10017969

Registration Number: NL-OMON34040

Lead Sponsor: Academisch Medisch Centrum

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: Not specified

Target Recruitment: 80

Inclusion Criteria

Patients with inflammatory bowel disease and IBS-like symptoms, age >11 years will be recruited. Patients have to be in remission of their inflammatory bowel disease as defined as no signs of inflammatory bowel disease, low inflammatory markers in laboratory tests and no disease activity on imaging studies of the intestine. IBS-like symptoms are defined as abdominal pain for at least two months, fulfilling the pediatric and adult Rome-III criteria for IBS

Exclusion Criteria

Exclusion criteria are a concomitant organic gastrointestinal disease, treatment by another health care professional for abdominal symptoms, mental retardation, insufficient knowledge of the Dutch language and previous hypnotherapy treatment.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary outcome will be the number of patients with > 50% reduction in<br /><br>intensity and frequency of abdominal pain. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcomes include the change in pain scores during follow-up, IBD<br /><br>disease activity score, quality of life scores, depression and anxiety scores,<br /><br>use of additional medication, health utility, societal costs, school absence<br /><br>and absence of work, measured after treatment and at 3 and 6 months follow-up. </p><br>